SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Herre J., Gordon S., Brown G.D. (2004) Dectin-1 and its role in the recognition of beta-glucans by macrophages. Mol Immunol 40: 86976.
  • 2
    Yadomae T., Ohno N. (1996) Structure-activity relationship of immunomodulating (1–>3)-beta-D-glucans. Recent Res Devel Chem Pharm Sci 1: 2333.
  • 3
    Adachi Y., Ishii T., Ikeda Y., Hoshino A., Tamura H., Aketagawa J., Tanaka S., Ohno N. (2004) Characterization of beta-glucan recognition site on C-type lectin, dectin 1. Infect Immun 72: 415971.
  • 4
    Dennehy K.M., Brown G.D. (2007) The role of the beta-glucan receptor Dectin-1 in control of fungal infection. J Leukoc Biol 82: 2538.
  • 5
    Saijo S., Fujikado N., Furuta T., Chung S.H., Kotaki H., Seki K., Sudo K., Akira S., Adachi Y., Ohno N., Kinjo T., Nakamura K., Kawakami K., Iwakura Y. (2007) Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat Immunol 8: 3946.
  • 6
    Hamuro J., Röllinghoff M., Wagner H. (1980) Induction of cytotoxic peritoneal exudate cells by T-cell immune adjuvants of the beta(1 leads to 3) glucan-type lentinan and its analogues. Immunology 39: 5519.
  • 7
    Hamuro J., Röllinghoff M., Wagner H. (1978) beta(1 leads to 3) Glucan-mediated augmentation of alloreactive murine cytotoxic T-lymphocytes in vivo. Cancer Res 38: 30805.
  • 8
    Hamuro J., Hadding U., Bitter-Suermann D. (1978) Solid phase activation of alternative pathway of complement by beta-1,3-glucans and its possible role for tumour regressing activity. Immunology 34: 695705.
  • 9
    Fujimoto S., Orita K., Kimura T., Kondo T., Taguchi T., Yoshida K., Ogawa N., Furue H. (1983) [Clinical evaluation of SPG (schizophyllan) as a therapeutic adjuvant after surgery of gastric cancer–controlled study by an envelope method]. Gan To Kagaku Ryoho 10: 113545.
  • 10
    Hong F., Yan J., Baran J.T., Allendorf D.J., Hansen R.D., Ostroff G.R., Xing P.X., Cheung N.K., Ross G.D. (2004). Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol 173: 797806.
  • 11
    Tada R., Harada T., Nagi-Miura N., Adachi Y., Nakajima M., Yadomae T., Ohno N. (2007) NMR characterization of the structure of a beta-(1–>3)-D-glucan isolate from cultured fruit bodies of Sparassis crispa. Carbohydr Res 342: 26118.
  • 12
    Harada T., Miura N.N., Adachi Y., Nakajima M., Yadomae T., Ohno N. (2002) Effect of SCG, 1,3-β-D-glucan from Sparassis crispa on the hematopoietic response in cyclophosphamide induced leukopenic mice. Biol Pharm Bull 25: 9319.
  • 13
    Ohno N., Miura N.N., Nakajima M., Yadomae T. (2000). Antitumor 1,3-beta-glucan from cultured fruit body of Sparassis crispa. Biol Pharm Bull 23: 86672.
  • 14
    Harada T., Kawaminami H., Miura N.N., Adachi Y., Nakajima M., Yadomae T., Ohno N. (2006). Comparison of the immunomodulating activities of 1,3-β-glucan fractions from culinary–medicinal mushroom, Sparassis crispa Wulf.:Fr. (Aphyllophoromycetideae). Int J Medicinal Mushrooms 8: 23144.
  • 15
    Ohno N., Nameda S., Harada T., Miura N.N., Adachi Y., Nakajima M., Yoshida K., Yoshida H., Yadomae T. (2003) Immunomodulating activity of a β-glucan preparation, SCG, extracted from a culinary–medicinal mushroom, Sparassis crispa Wulf.:Fr. (Aphyllophoromycetideae), and application to cancer patients. Int J Medicinal Mushrooms 5: 37381.
  • 16
    Harada T., Masuda S., Arii M., Adachi Y., Nakajima M., Yadomae T., Ohno N. (2005) Soy isoflavone aglycone modulates a hematopoietic response in combination with soluble beta-glucan: SCG. Biol Pharm Bull 28: 23425.
  • 17
    Ohno N., Harada T., Masuzawa S., Miura N.N., Adachi Y., Nakajima M., Yadomae T. (2002) Antitumor activity and hematopoietic response of β-glucan extracted from an edible and medicinal mushroom Sparassis crispa wulf.:Fr (Aphyllophoromycetideae). Int J Medicinal Mushrooms 4: 1326.
  • 18
    Nameda S., Harada T., Miura N.N., Adachi Y., Yadomae T., Nakajima M., Ohno N. (2003) Enhanced cytokine synthesis of leukocytes by a β-glucan preparation, SCG, extracted from a medicinal mushroom, Sparassis crispa. Immunopharmacol Immunotoxicol 25: 32135.
  • 19
    Harada T., Miura N.N., Adachi Y., Nakajima M., Yadomae T., Ohno N. (2002) IFN-gamma induction by SCG, 1,3-beta-D-glucan from Sparassis crispa, in DBA/2 mice in vitro. J Interferon Cytokine Res 22: 122739.
  • 20
    Harada T., Miura N.N., Adachi Y., Nakajima M., Yadomae T., Ohno N. (2008) Highly expressed dectin-1 on bone marrow-derived dendritic cells regulates the sensitivity to beta-glucan in DBA/2 mice. J Interferon Cytokine Res 28: 47786.
  • 21
    Harada T., Nagi Miura N., Adachi Y., Nakajima M., Yadomae T., Ohno N. (2003) Antibody to soluble 1,3/1,6-beta-D-glucan, SCG in sera of naive DBA/2 mice. Biol Pharm Bull 26: 12258.
  • 22
    Harada T., Ohno N. (2008) Contribution of dectin-1 and granulocyte macrophage-colony stimulating factor (GM-CSF) to immunomodulating actions of beta-glucan. Int Immunopharmacol 8: 55666.
  • 23
    Harada T., Kawaminami H., Miura N.N., Adachi Y., Nakajima M., Yadomae T., Ohno N. (2006) Mechanism of enhanced hematopoietic response by soluble beta-glucan SCG in cyclophosphamide-treated mice. Microbiol Immunol 50: 687700.
  • 24
    Harada T., Kawaminami H., Miura N.N., Adachi Y., Nakajima M., Yadomae T., Ohno N. (2006) Cell to cell contact through ICAM-1-LFA-1 and TNF-alpha synergistically contributes to GM-CSF and subsequent cytokine synthesis in DBA/2 mice induced by 1,3-beta-D-Glucan SCG. J Interferon Cytokine Res 26: 23547.
  • 25
    Rosas M., Gordon S., Taylor P.R. (2007) Characterisation of the expression and function of the GM-CSF receptor alpha-chain in mice. Eur J Immunol 37: 251828.
  • 26
    Adachi Y., Okazaki M., Ohno N., Yadomae T. (1994) Enhancement of cytokine production by macrophages stimulated with (1–>3)-beta-D-glucan, grifolan (GRN), isolated from Grifola frondosa. Biol Pharm Bull 17: 155460.
  • 27
    Ohno N., Asada N., Adachi Y., Yadomae T. (1995) Enhancement of LPS triggered TNF-alpha (tumor necrosis factor-alpha) production by (1–>3)-beta-D-glucans in mice. Biol Pharm Bull 18: 12633.
  • 28
    Ozment-Skelton T.R., Goldman M.P., Gordon S., Brown G.D., Williams D.L. (2006) Prolonged reduction of leukocyte membrane-associated Dectin-1 levels following beta-glucan administration. J Pharmacol Exp Ther 318: 5406.